May 23, 2019
Lung Cancer Research Foundation Announces New Scientific Advisory Board Chair
May 22, 2019
Over 100 Inhouse Validated Xenograft Models for Preclinical Testing by Altogen Labs
May 20, 2019
DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
Apr 30, 2019
Ohio Cancer Research Announces New Executive Director
Apr 30, 2019
The Lung Cancer Research Foundation and Pfizer Announce Collaboration in Lung Cancer Research
Apr 17, 2019
Biotech Brief: Optimism Rising for Cancer Treatment Advancements in 2019
Apr 09, 2019
IO Combinations 360° Summit Announces Keynotes and Program Line-Up for the 4th Annual Event
Apr 04, 2019
CStone Pharmaceuticals presented poster of pre-clinical result for CS1003 at AACR
Apr 03, 2019
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Mar 31, 2019
For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size
Mar 31, 2019
Stand Up To Cancer-supported Clinical Trials Seeking To Extend CAR T-cell Therapy to Solid Tumors, Reported at AACR Annual Meeting
Mar 26, 2019
Biotech, science, medical coalition launches Metabo-oncology.com to help solve deadly cancer-obesity crisis
Mar 25, 2019
Stand Up To Cancer Grants First Peggy Prescott Award In Colorectal Cancer Research
Mar 20, 2019
Enterome Announces Research Collaboration with Renowned US Cancer Institute Focused on New Microbiome-derived Cancer Immunotherapy
Mar 18, 2019
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.
Mar 12, 2019
xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
Mar 05, 2019
Biotech Companies Intensify Research Into New Therapies to Combat Cancer
Mar 01, 2019
Many Look Beyond Chemotherapy to Combat the Swelling Incidence of Cancer
Feb 28, 2019
Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting
Feb 21, 2019
Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies